Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
The availability of agents that block the biological activity of tumor necrosis factor alpha (TNF alpha) in rheumatoid arthritis (RA) has permitted studies that confirm the key role of this cytokine in the pathogenesis of this disease. To date, two anti-TNF agents, infliximab and etanercept, have be...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2001
|